At about $1.70 per wafer, thats roughly $100/month for therapeutic dosing compared to $600-1,200+ for IV treatments that carry real risks and require constant clinic visits
They exhibit high solubility, low viscosity, and are easily incorporated into various formulations [59]
J Nanobiotechnol 22(1):91
Additionally, Yamada and colleagues, using neonatal rats, demonstrated that zinc deficiency alters MTN membrane properties and spike discharge patterns
In another systematic review that included individuals with T2D from 38 phase III or IV placebo-controlled randomized controlled trials with GLP-1RAbased therapy (16), nausea was reported in 19.3% of participants with active treatment versus 6.5% with placebo, and vomiting was reported in 7.6% of participants versus 2% with placebo